Division of Innovative Pathology and Laboratory Medicine(Kashiwa)

We aim to create real-world clinical specimen information by linking abundant clinical, biological, and morphological information to provide a basis for treatment sensitivity of cancer.

We work together with clinicians and companies to develop new diagnostic and therapeutic methods and to search for biomarkers using a wealth of histopathological specimens and detailed clinical information. In particular, we have more than 7,000 Tissue Micro-Arrays (TMAs), all of which are linked to pathological and clinical information.

Tissue micro array（more than 7000）

In vitro cancer microenvironment analysis model using cells isolated and cultured from human cancer tissue (cancer associated fibroblasts; CAFs).

Creation of additional pathological diagnostic information by using digital images and machine learning techniques